Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lavipharm signs agreement with Sanofi to acquire Flagyl
Lavipharm has signed an agreement with Sanofi to acquire the pharmaceutical product, Flagyl, for the Greek market, for an undisclosed sum.
Production & Sales
-
12 Dec 2023
-
14 Nov 2023
Otsuka Pharmaceutical submits NDA for voclosporin in Japan
Aurinia Pharmaceuticals’ collaboration partner Otsuka Pharmaceutical has submitted a new drug application (NDA) to the Japanese Ministry of Health, Labour and Welfare for voclosporin to treat lupus nephritis (LN).
-
26 Oct 2023
Mithra signs license agreement with Searchlight for Donesta in Canada
Mithra Pharmaceuticals has entered into a license and supply agreement with Searchlight Pharma for the Canadian rights to Donesta.
-
20 Oct 2023
Aldena chooses PCI to manufacture injectable dermatological treatment
Aldena Therapeutics has selected PCI Pharma Services (PCI) for manufacturing and distributing of ALD-102, an investigational treatment for dermatological diseases.
-
11 Oct 2023
Y.S.P. Industries to market TaiGen’s new drug in Malaysia and Singapore
Y.S.P. Industries has entered into an exclusive licensing agreement to develop and market TaiGen Biopharmaceuticals Holdings’ (TaiGen) new drug in Malaysia and Singapore.
-
04 Oct 2023
BridgeBio and Resilience partner to develop gene therapies
BridgeBio Pharma has entered into a strategic partnership with National Resilience (Resilience) for the manufacturing and advancement of two investigational gene therapies, BBP-812 and BBP-631.
-
03 Oct 2023
Cambrex concludes capacity expansion at High Point facility in US
Cambrex has concluded the expansion of capacity at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina, US.
-
25 Sep 2023
Lupin acquires five brands and associated trademark rights from Menarini
Indian pharmaceutical firm Lupin has entered into an agreement to acquire five brands along with associated trademark rights from the units of Menarini -- A. Menarini India Private Limited and A. Menarini Asia-Pacific Holdings.
-
21 Sep 2023
WuXi XDC opens new GMP facilities in China
WuXi XDC has launched new commercial Good Manufacturing Practices (GMP) facilities in Wuxi, Jiangsu Province, China.
-
05 Sep 2023
Novo Nordisk launches Wegovy for obese patients in UK
Novo Nordisk has launched Wegovy (semaglutide injection) as an adjunctive treatment for obese patients in the UK.